Electronic nicotine delivery systems: the need for continued regulatory innovation

Area of Science:

• Public Health
• Tobacco Regulatory Science
• Addiction Medicine

Background:

• The widespread adoption of electronic nicotine delivery systems (ENDS) presents significant challenges to global tobacco regulatory frameworks.
• Existing regulations struggle to address both adolescent uptake and the potential public health benefits of ENDS for adult smokers.

Purpose of the Study:

• To review current US Food and Drug Administration (FDA) regulatory strategies for tobacco products, focusing on nicotine concentration and youth prevention.
• To explore the applicability of a harm reduction model, drawing parallels with successful interventions in other markets like opioid addiction treatment.
• To propose a novel regulatory framework for ENDS based on harm reduction principles.

Main Methods:

• Review of recent FDA regulatory actions concerning tobacco products.
• Analysis of harm reduction strategies employed in other public health domains (e.g., opioid therapy).
• Development of a proposed harm reduction framework for ENDS regulation.

Main Results:

• Current regulatory approaches are being challenged by the rapid growth of ENDS.
• Harm reduction strategies, proven effective in other fields, offer a potential model for ENDS regulation.
• A tiered nicotine exposure standard coupled with risk-based distribution controls could facilitate market entry for safer ENDS products.

Conclusions:

• A harm reduction approach to ENDS regulation is feasible and could significantly benefit public health.
• Implementing tiered nicotine standards and risk-based controls can help ENDS meet public health protection requirements.
• This strategy can facilitate the transition of adult smokers to ENDS while mitigating risks of adolescent initiation and addiction.